Tubular Markers in Response to Saxagliptin Therapy
Condition(s):Diabetes Mellitus, Type 2Last Updated:August 20, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes Mellitus, Type 2Last Updated:August 20, 2020Completed
Condition(s):Coronary Artery Disease; Diabetes Mellitus Type 2Last Updated:June 18, 2014Completed
Condition(s):Type 1 DiabetesLast Updated:July 6, 2016Unknown status
Condition(s):Impaired Glucose ToleranceLast Updated:January 13, 2020Terminated
Condition(s):Type 2 Diabetes Mellitus; Cardiovascular DiseaseLast Updated:May 29, 2015Terminated
Condition(s):Diabetes MellitusLast Updated:June 23, 2017Completed
Condition(s):Type2 Diabetes MellitusLast Updated:June 20, 2018Completed
Condition(s):Impaired Glucose ToleranceLast Updated:February 3, 2015Completed
Condition(s):Type 2 DiabetesLast Updated:February 15, 2019Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:May 5, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.